June 1, 2017
Vertex has good news for 500 Irish patients with cystic fibrosis
Vertex Pharmaceuticals Incorporated has reached an agreement with the Health Service Executive (HSE) in the Republic of Ireland to fund Orkambi (lumacaftor/ivacaftor).